Immune Disorders Study Guide
Immune Disorders Overview
14.1 Immune Deficiency
Primary Immune Deficiencies
Genetic conditions affecting the immune system.
Severe Combined Immunodeficiency (SCID)
Affects T1 cells and leads to severe vulnerability to infections.
Caused by adenosine deaminase (ADA) deficiency and DiGeorge syndrome.
Results in recurrent fungal, protozoan, and viral infections.
Lymphoid Stem Cell Disorders
Disorders that affect T lymphocytes include pre-T cell and pre-B cell lymphoid stem cells.
B Cell Deficiencies
Deficiencies such as agammaglobulinemia and hypogammaglobulinemia lead to recurrent bacterial infections due to inadequate antibodies.
Secondary Immune Deficiencies
Acquired immunodeficiencies due to external factors.
Examples:
AIDS: Caused by HIV that targets CD4+ T cells.
Cancer: Can compromise immune function.
Aging: Natural decline in immune efficiency.
Pregnancy: Physiological changes affecting immunity.
Immunosuppressive Therapy: Treatments that weaken the immune response.
14.2 Hypersensitivity
Types of Hypersensitivity Reactions:
Type I: IgE-mediated responses (e.g., allergies, asthma).
Type II: IgG/IgM-mediated cell lysis (e.g., blood transfusion reactions).
Type III: Immune complex-mediated reactions (e.g., serum sickness).
Type IV: T-cell mediated (e.g., delayed-type hypersensitivity).
Type I Hypersensitivity (Allergy)
Mechanism:
First exposure does not cause symptoms but creates memory cells.
Subsequent exposures trigger activation of memory response leading to:
IgE production.
Degranulation of mast cells and basophils leading to chemical mediators release (e.g., histamine).
Local symptoms: swelling, itching, nausea, vomiting (due to increased peristalsis).
Systemic symptoms: airway obstruction, hives, drops in blood pressure.
Atopy:
Genetic predisposition to develop allergic reactions.
Affects 10-30% of the population.
Influenced by genetic and environmental factors (e.g., microbiome hypothesis).
Anaphylaxis:
A severe, systemic allergic reaction.
Mechanism Detail
Sensitization Process:
Allergen exposure via dendritic cells.
Activation of allergen-specific Th2 cells, and the release of cytokines (IL-4, IL-5).
B cells produce allergen-specific IgE.
IgE binds to mast cells causing degranulation, releasing mediators:
Histamine, leukotrienes, cytokines, prostaglandins, and platelet activating factor (PAF).
Symptoms from Chemical Mediators:
Histamine: increases blood vessel permeability, leading to swelling and redness.
Leukotrienes: cause bronchoconstriction and mucus buildup, complicating asthma.
Therapy for Type I Hypersensitivity
Diagnosis:
Skin tests for allergens.
Common Treatments:
Antihistamines (e.g., Benadryl - Diphenhydramine Hydrochloride): provides relief for sneezing, runny nose, itchy throat, and watery eyes.
Desensitization/Vaccination: decreasing IgE levels and increasing IgG levels against allergen.
14.3 Types of Hypersensitivity
Type II Hypersensitivity (ABO & Rh):
Antigen-antibody reactions lead to cell agglutination and lysis during blood transfusion mismatches.
ABO Blood Group:
Determined by A & B antigens on red blood cells.
Type O is universal donor; Type AB is universal recipient due to the absence of anti-A/B antibodies.
Rh Factor:
Important in pregnancy where an Rh- mother carries an Rh+ fetus, resulting in potential hemolytic disease of the newborn (HDN).
Treatment: RhoGAM administration to prevent maternal anti-Rh antibody production.
Type III Hypersensitivity:
Immune complex formation leads to local inflammation and tissue damage.
Examples include Arthus reactions (localized) and systemic serum sickness from animal serum.
Type IV Hypersensitivity (DTH):
T-cell mediated responses like contact dermatitis from poison ivy and tuberculin skin tests.
Tissue Transplantation
Rejection Mechanisms: T cells react against non-self MHC (major histocompatibility complex).
Types of grafts:
Autograft: from the same individual.
Isograft: from genetically identical twin.
Allograft: from a genetically different organism of the same species.
Xenograft: from a different species.
Graft-versus-host disease (GVHD): A severe complication post-transplantation where transplanted immune cells attack host tissues.
Critical Thinking Question:
How can preimplantation genetic diagnosis (PGD) improve allograft success rates?
Autoimmunity
Self-antigens triggering immune response against the body’s own tissues.
Understanding autoimmune disorders is essential for recognizing how the immune system can misinterpret body cells as foreign.